Skip to content

Acute Whole Body Vibration Change the Glycemic and Lactate Levels

Acute Whole Body Vibration Decrease the Glucose Levels in Elderly Diabetic Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03542929
Enrollment
29
Registered
2018-05-31
Start date
2017-11-20
Completion date
2018-04-30
Last updated
2018-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

The type II diabetes is characterized by high levels of blood glucose followed by excessive insulin release so that the target cells become less sensitive and develop insulin resistance, maintaining hyperglycemic levels. The Whole body vibration session may improve the glucose metabolism in diabetic patients by reducing the peripheral blood sugar. Ten healthy elderly women and eight diabetic elderly women were allocated into two groups, and have made an acute whole body session.

Interventions

DEVICEwhole body vibration

whole body vibration training on a vibrating platform with healthy elderly and diabetic elderly

Sponsors

Maíra F Pessoa
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Masking description

A researcher was performed the interventional protocol and a different researcher was made the evaluations

Eligibility

Sex/Gender
FEMALE
Age
60 Years to 74 Years
Healthy volunteers
Yes

Inclusion criteria

* elderly between 60 to 74 years, * sedentary according the International Physical Activity Questionnaire (IPAQ- short form) * For diabetic group, were considered who those medical diagnoses of type II diabetes for at least 02 complete years, who had used only oral hypoglycemic agents of biguanides class (Metformin extended release - XR) in dosage between 500 to 850 mg. * For healthy elderly group were considered elderly women without self-reported diseases

Exclusion criteria

* diabetic volunteers who have ingested the breakfast less than 02 hours or more than 03 hours and those who have taken Metformin less than 02 hours before the intervention. For all volunteers, the complementary

Design outcomes

Primary

MeasureTime frameDescription
Changes in glucose levelsbefore and immediately after the 10 minute interventionA digital puncture with disposable lancets was collected a peripheral blood drop in the specific strip for the home glucose monitoring AccuChek Active® (Roche Diagnostics GmbH, Mannheim, Germany) according to International Organization for Standardization (ISO) recommendations in 2013 (11).
Changes in lactate levelsbefore and immediately after the 10 minute interventionAnother peripheral blood drop was collected from the same digital puncture with disposable lancets and put in the specific strip for to check the seric blood lactate, which was analyzed by a portable lactimeter Accutrend Plus ® (Roche Accutrend Plus, New York, USA).

Secondary

MeasureTime frameDescription
peripheral oxygen saturation (SpO2)before and immediately after the 10 minute interventionmeasured with a digital oximeter Onyx (Nonim, model 9500, USA)
heart rate (HR)before and immediately after the 10 minute interventionmeasured with a digital oximeter Onyx (Nonim, model 9500, USA)
Borg's Rating of Perceived Exertion Scale (RPE) or Modified Borg Scalebefore and immediately after the 10 minute interventionvisual scale that measure the perceived exertion in muscle or dyspnoea, measuring values between 0 at 10

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026